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1.  Background 
•  <  )n 25 January  1996 the Commission suhtlliHed a proposal  fi.>r a European Parliament 
and Council Directive on the legal protection ofhiotechnological invenHons.' 
•  The Economic and Social Committee delivered its opinion on  II July 1996.2 
•  Parliament delivered its opinion at first reading on 16 July 1997.  J 
•  The Commission presented an amended proposal on 29 August 1997.4 
2.  Content of  the Commission proposal 
The aim  of the  proposal  for  a  Directive  is  to  establish clear provisions  under which 
biotechnological  inventions  will  enjoy  the  same  level  of protection  by  patent  in  all 
Member States.  To  this  end,  it  elucidates  the  application  of existing  patent  law.  It 
incorporates a numher of  definitions and rules of interpretation which seck to clarify what 
can and what cannot he  patented and lo resolve the differentiation issues raised hy  plant 
production  rights.  It also  lays  down  provisions  designed  to  ensure  that  patent offices 
fi.>llow  unil<>rm  practices in  issuing  patents  and  to  achieve  uniform  national  case-law; 
particularly as  regards  inventions whose commercial exploitation would be contrary to 
public policy or morality.  Finally, the proposal determines the scope of the protection 
provided by a patent on a biotechnological invention. 
Following  Parliament's  rejection  of the  joint  text,  approved  by  the  Conciliation 
Committee, for a European Parliament and Council Directive on the legal protection of 
biotechnological  inventions,5  Parliament  and  the  Council  determined  that  the  legal 
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-2-The situation which led  to the  first  proposal  in  19881•  applies equally  today. as  regards 
both the expanding niarket  f(n biotechnological products and lack of certainty ahout the 
application of existing patent law. This uncertainty  is  liahle to  hamp~:r the  workings of 
the  single  market  and  investment  in  product  research  or  research  into  new 
biotechnological techniques. 
3.  Remarks on the common position 
3.1  General observations 
Acting  by  qualified  majority,  the  Council  endorsed  the  approach  taken  in  the 
Commission's amended proposal incorporating Parliament's amendments at first reading. 
It thereby  acknowledged  that  the  two  issues  of most  importance  to  Parliament- the 
patentability  of  individual  parts  of the  human  body  and  the  ethical  aspect  of 
biotechnological inventions - had to be dealt with directly under patent law. 
3.2  Amendments adopted by Parliament at first reading 
The  amendments  accepted  by  the  Commission  and  incorporated  into  its  amended 
proposal have also been incorporated into the common position. They are as follows: 
Amendment 1  Recital 19 
Amendment2  Recital3 
Amendment3  Recital4 
Amendment 5  Recital 9 
Amcndment6  Recital to 
Amendment 7  Recital  11 
Amendment 8  Recital 12 
Amendment 9  Recital 14 
Amendment 11  Recital  16 
Amendment 12  Recitall7 
Amendment 13  Recital  18 
Amendment 14  Recital20 
Amendment 15  Recital21 
Amendments 16, 99, 17 and 79  Recitals 22-28 
Amendment 18  Recital29 
Amendment 19  Recital30 
Amendment 20  Recital31 
Amendment 21  Recital32 
Amendment 22  Recital33 
Amendment 23  Recital·34 
Amendment 24  Recital35 
Amendment 26  Recital36 
Amendment 27  Recital 37 
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Amendment 3  7 
Amendment 38 
Amendment 39 
Amendments 40, 67 and 68 
Amendments 41, 42, 77 and 43 
Amendment 44 
Amendment 48 
Amendment 4 7 















Amendment  63 
Amendment 64 










Article 16(  c) 
Article 1  (2) 
Recital 55 
Recital 56 
Articles 2 and 3 
Article 4 
Article 5 
Article 4 of  the original proposal deleted 
Article 5 of  the original proposal deleted 
Article 6 of  the original proposal deleted 
Article 7 of  the original proposal deleted 
Article 8 of  the original proposal deleted 





Article II (2) 
Article 12(3)(b) 
Article 12(4) 
Article 17 of  the original proposal deleted 
Article 15( 1  ), first subparagraph 
Article 16(a) 
-4-3.3  Amendments tabled during the Council discussion 
Recital22 
The Council thought it appropriate to incorporate into  Recital 22  the content of Recitals 
l6c and  16e, proposed  by  Parliament's Amendment  I  6.  The technical content of these 
recitals is similar and may be incorporated into a single statement. 
Recitals 24 and 25 
The  Council  thought  it  preferable  to  divide  Recital  16d,  proposed  by  Parliament's 
Amendment  16,  into two separate recitals.  The first part of Recital  16d relates to  the 
conditions  governing  patentability,  particularly  the  need  to  respect  the  criterion  of 
industrial application. The second part refers to the scope of  the protection provided by a 
patent.  In  order to  avoid  confusion of any  sort, the Council  therefore decided  that the 
technical  content of this  recital  would  be  clearer if it were  divided  into  two  separate 
recitals. 
Recita126 
This  recital  incorporates  Recital  1  6g,  proposed  by  Parliament's  Amendment  17.  The 
Council  has altered the wording slightly  in  order to emphasise that the  verification of 
consent is necessarily su~ject to the principle of  subsidiarity. 
Recital27 
This  recital  is  new.  It  incorporates  to  some  extent  the  idea  behind  paragraph  1  of 
Amendment 76/rev, which the Commission was unable to accept as part of its amended 
proposal.  The  Council  took  the  view that the  most  appropriate  approach  was  for the 
inventor voluntarily to provide information on the geographical origin of the biological 
material used for the invention. 
Recital 33 
Parliament's Amendment 22  defined with some  technical  precision the  concept of an 
essentially  biological  procedure for  the  breeding of plans  and  animals.  To  avoid any 
problems of interference between Article 2(2) of the draft Directive, which defines this 
idea, and  Recital  33,  the Council thought it preferable that the technical  aspects of the 
concept should be incorporated into Article 2(2). As a result, Recital 33 now reads like a 
statement of  the issue. 
- 5-Recital 19c of  the amended proposal 
Recital  19c  of the  amended  proposal  corr(!sponded  to  Recital  I 9d  as  proposed  by 
Parliament's Amendment 26. However, the Commission took the view that the final part 
of the recital should  not  be  included, as it  could lead  to  confusion between compliance 
with  the  conditions  governing  patentability  and  the  need  to  respect  the  procedures 
relating  to  authorisation  of commercial  exploitation.  The  Council  noted  that  what 
remained of Recital  l9c was still  open  to  misinterpretation.  It therefore decided  not  to 
incorporate it into its common position. 
Recital }9 
The  wording  of Recital  3~,  incorporating  Parliament's  Amendment  30,  has  been 
amended to some extent. The Council thought it more appropriate to take the view that it 
is the ethical and moral principles which correspond to public order and morality in the 
Member States. This is closer to the context of  Article 6. 
Recital41 
The Council deemed it necessary to amend the wording used  by  the Commission in  its 
amended proposal so as to  make it more precise. As regards the definition of processes 
for  the  cloning  of human  beings,  it  became  apparent  that  the  technique  of embryo 
splitting needed to be taken into consideration, in the same way as the technique based on 
replacement of  the nucleus. 
Recital42 
The Council  thought  it  important to  incorporate  this  new recital,  which  includes  the 
details necessary for a full understanding of  the scope of  the exclusion from patentability 
of  the uses of  embryos referred to in Article 6(2)(  c). 
Recital43 
The Council took the view that, as regards rcJerences to the protection of human rights, it 
was  not  appropriate tor a directive harmonising natiorial  laws  to  refer to  a convention 
which has not yet entered into f(wce and which has not been signed by all Member States. 
This is  why  Recital  43  no  longer refers to  the Council of Europe's Convention  f(lr  the 
Protection  of Human  Rights ,and  Dignity  of the  Human  Being  with  regard  to  the 
Application of Biology and Medicine: Convention on Human Rights and Biomedicine of 
19 November 1996.  As  regards the European Convention tor the Protection of Human 
Rights and Fundamental Freedoms of  4 November 1950, the Council took the view that it 
was more appropriate to refer to Article F(2) of  the Treaty on European Union. 
- 6-Recital44 
This  new  recital  refers  to  the  European  <lroup  on  Ethics  in  Science  and  New 
Technologies,  which  replaces  the  ( iroup or advisers on  ethics and  biotechnology.  The 
remit or this new group has hcen  bromkncd to  include sciences anlf  new technologies, 
including biotechnology.  Recital  44 defines the  precise context  in  which  the  European 
Uroup on Ethics will operate. 
Recital45 
The Council considered it necessary to extend the criteria for substantial medical benefit 
by referring to research and prevention, in addition to diagnosis and therapy. 
Recital 35 of the amended proposal 
The Council took the view that  it  was more appropriate to transfer the content of this 
recital  to  the  main  body or the text.  Article 16 of the  amended  proposal  called on  the 
Commission to draw up a report  l<lr  Parliament and the Council. There would thus have 
been little point in a recital's laying down the same requirement The Council decided it 
made more sense to place this stipulation in a single article. As a result, Recital 35 of  the 
amended proposal has been deleted and an addition made to Article I  6. 
Recital 36 of  the amended proposal 
See the remarks on Recital35. 
Article 1 
The  Council  took  the  view  that  it  was  not  appropriate  to  mention  in  Article I (2) 
Member States' rights in  relation to  international agreements which arc not liable to  be 
aflccted by the Directive. Only the Member States' obligations must be mentioned here. 
Article 2 
The  Council  thought  it  more  appropriate  that  Article 2(2)  should  incorporate  all  the 
technical aspects of the definition of an essentially biological process for the production 
of  plants or animals (see remarks on Recital 33). 
Article 6 
The Council considered it more accurate to replace the expression 'procedures for human 
reproductive  cloning'  by  the  expression  'processes  for  cloning  hHman  beings'  in 
paragraph 2(a). Recital41-defines such procedures. 
- 7-In  Article 6(2)(c),  the  Council  decided  to  replace  the  expression  'methods  in  which 
human  embryos  arc  used'  by  'uses  of human  embryos  for  industrial  or commercial 
purposes'. Recital 42 clarities the nature of  such uses. 
Article 7 
The  Council  thought  it  more  advisable  to  say  that  the  European  ( iroup  on  Ethics  in 
Science and  New Technologies  'evaluates' all  ethical  aspects of biotechnology,  rather 
than that it 'shall assess' such aspects. Recita144 describes the scope of  such evaluation. 
Article 11 
The Council deemed it necessary to harmonise the wording used in paragraphs 1 and 2, 
so as to avoid ditliculties of  interpretation. 
Article 12 
As regards paragraph 4, the Council decided that it was important to refer to Article 29 of 
Regulation ( EC)  No 2 I  00/94 in cases where a licence tor a plant variety can he  granted 
only by the Community Plant Variety Office. 
Article 15 
As regards paragraph  I, the Council thought it more advisable for the deadline for the 
entry into force of  the Directive in the Member States to be set for a particular date after 
the  date  of the  Directive's  publication  in  the  Official  Journal  of the  European 
Communities. 
Article 16 
As  noted  in  the remarks on  Recitals 35  and 36 of the  amended  proposal, the Council 
considered  it  more advisable  for  the  reports  which  the Commission  is  to  draw up  for 
Parliament and the Council to be referred to in an article. 
As regards (c), it should be noted that the Council decided that the Commission's annual 
report  on  the  development  of patent  law  in  the  1ield  of biotechnology  and  genetic 
engineering should also consider the implications of  such development. 
3.4  Commission position on the amendments tabled by the Council 
The Commission accepted the amendments arising from the Council's discussions. 
4.  Conclusions 
The  Commission  believes  that  the  common  position  incorporates  and  completes  as 
appropriate the amendments accepted at first reading.  Moreover, the Council has made a 
number of  changes which constitute technical improvements to the amended proposal. 
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